WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 22'5301 Infant (under 12 months) mortality rate: 42
GDP / capita (US$): 25'6511 Child (under 5 years) mortality rate: 52

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 11'128  11'125  11'119  11'110  11'098  10'987  10'161  9'643 
Births 108  110  111  112  113  103  105  143 
Surviving infants 108  110  111  112  112  103  104  140 
Pop. less than 5 years 566  576  578  567  559  524  552  718 
Pop. less than 15 years 1'630  1'631  1'626  1'613  1'607  1'669  1'956  2'200 
Female 15-49 years 2'509  2'531  2'554  2'578  2'602  2'744  2'427  2'331 

Number of reported case

(Click for retrospective incidence data for Greece)
Diphtheria
Japanese encephalitis
Measles 40  149  56  245  13'464 
Mumps 21  32 
Pertussis 28  56  64  27  13  752  3'083 
Polio*
Rubella 12 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 11  16  16  15 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Greece)
Vaccine year result method % card seen                                                
BCG          35  35  91  91  88 
DTP1          100  100  100  100 
DTP3          100  100  99  99  54  72 
HepB_BD         
HepB3          98  98  95  95 
Hib3          95  95  83  83 
JapEnc         
MCV          99  99  99  99  76 
MCV2          83  83  77  77 
PCV1          94  94 
PCV3          32  32 
Pol3          100  100  99  99  96  90 
Rota1         
Rota_last         
Rubella1          99  98  98 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Greece)
BCG 86  95 
DTP1 99  99  99  99  99  96  77  89 
DTP3 99  99  99  99  99  89  54  72 
HepB3 98  98  95  95  95  89 
HepB_BD
Hib3 94  94  83  83  83  87 
MCV 99  99  99  99  99  89  76 
MCV2 83  83  77  77  77 
PCV3 32  32  32  32  32 
Pol3 99  99  99  99  99  89  96  90 
Rota_last

Number of districts in the country 54  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 6 years; Yes
DTaP 2, 4, 6, 15-18 months; 4-6 years; Either DtaP or other combination vaccine
HPV 11-18 years (x3); Yes
HepA > 12 months (x2); +6 months Yes
HepB 2, 4, 6 months; Yes Either monovalent or combination vaccine; 3 doses for >= 19 years; birth dose for risk groups
Hib 2, 4, 6, 12-15 months; Yes Administered in various combination types of vaccines
IPV 2, 4, 6-18 months; 4-6 years; Yes
MMR 12-15 months; 4-6 years; Yes
MenACWY 11-18 years; Yes
MenC_conj 2, 4, 6-71 months; Yes
Pneumo_conj 2, 4, 6, 12-15 months; 2-3, 50 years; Yes for the dose administered at 2-3 years, PCV13 only for children vaccinated with PCV7 or PCV10
Pneumo_ps >= 50 years; Yes persons 2-50 years belonging to high risk groups
Td Yes 10 years after TdaP and every 10 years afterwards
Tdap 11-12 years; Yes
Varicella 12-15 months; 4-6 years; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR       No  No  No  No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number              

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes         

System performance

Total Nº districts in country number 54  54  54  54  54     
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100%    
Nº districts with measles (MCV1) coverage >=95% number              
% of districts with MCV1 coverage >=95% From 0 to 100%            

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND              
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR             No 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%              

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.